Paper Details 
Original Abstract of the Article :
BACKGROUND: Drug-induced immune hemolytic anemia (DIIHA) is a rare but potentially life-threatening pharmacogenic hematological adverse effect. Updating the risk of DIIHA among the currently available drugs based on spontaneously reported adverse event data is of great significance. OBJECTIVE: This...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1177/10600280231189897

データ提供:米国国立医学図書館(NLM)

Unveiling the Hidden Dangers: Drug-Induced Immune Hemolytic Anemia

This study delves into the intricate world of drug-induced immune hemolytic anemia (DIIHA), a rare but potentially life-threatening adverse drug reaction. The research analyzed data from the US Food and Drug Administration Adverse Event Reporting System (FAERS) database to identify the top 50 drugs associated with DIIHA in adults and common drugs that could cause DIIHA in children. The study found that the top three categories of drugs associated with DIIHA are antineoplastic agents, immunosuppressants, and antibiotics for systemic use. The study also identified the top five drugs with the highest reported odds ratio (ROR) and proportional reporting ratio (PRR) for DIIHA in adults and children. This research provides valuable insights into the potential risks of various drugs, helping healthcare professionals to make informed decisions about drug selection and patient management.

The Silent Threat of DIIHA: A Call for Vigilance

The study highlights the importance of being aware of the potential for DIIHA, a serious adverse reaction that can be triggered by various medications. Healthcare professionals need to be vigilant in monitoring patients for signs and symptoms of DIIHA, particularly those taking drugs identified as potential triggers. Early diagnosis and intervention can be crucial for preventing severe complications associated with DIIHA.

Navigating Drug Therapy: A Balance of Risks and Benefits

This research emphasizes the need for careful consideration of the potential risks and benefits of various drug therapies. While medications offer valuable benefits in treating various conditions, it's crucial to weigh the potential for adverse effects, such as DIIHA, against the potential benefits of treatment. This requires open communication between patients and healthcare providers to ensure informed decision-making about medication choices.

Dr. Camel's Conclusion

Think of the human body as a delicate desert ecosystem, where even a seemingly harmless flower can contain a hidden sting. This research reminds us that even seemingly safe medications can hold potential dangers, and we must be vigilant in identifying and mitigating these risks to protect our health and well-being.

Date :
  1. Date Completed n.d.
  2. Date Revised 2023-07-31
Further Info :

Pubmed ID

37522435

DOI: Digital Object Identifier

10.1177/10600280231189897

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.